Latest Strategy News

Hazer Group has extended its collaboration with South Korean steel giant POSCO to further integrate its clean hydrogen and low-emissions graphite technology into low-carbon steel production.

Cobre Limited has confirmed the continuity of higher-grade copper-silver mineralisation at its Cosmos Target within Botswana’s Ngami Copper Project, prompting an extension of its drilling program to further delineate the resource.

Pursuit Minerals has satisfied all acquisition conditions for the Sascha Marcelina Gold Project in Argentina and is advancing exploration with a focus on high-potential drill targets. Concurrently, the company progresses its Rio Grande Sur Lithium Project feasibility study, positioning itself for dual-commodity growth.

Wildcat Resources has signed a pivotal Native Title Agreement with the Nyamal people, clearing a major hurdle for the Tabba Tabba lithium project in Western Australia's Pilbara region.

DPM Metals has announced a substantial inferred mineral resource at its Rakita Camp in Serbia, highlighting 2.6 million ounces of gold and 1.9 billion pounds of copper. This milestone underscores the camp's potential as a district-scale gold-copper system with promising growth prospects.

Rox Resources has opened a $10 million Share Purchase Plan at a 19.9% discount, inviting eligible shareholders to invest in the development of its Youanmi Gold Project. The offer runs through mid-December, aiming to bolster exploration and working capital.

Asian Battery Metals confirms a significant 30% strike extension of sulphide mineralisation at its Oval Cu-Ni-PGE project in Mongolia, supported by new drillhole visuals and assay results. The company advances plans for deeper drilling and regional exploration to build a critical metals cluster.

Austin Engineering Limited has announced an on-market buy-back of its ordinary shares, set to run from December 2025 through October 2026, signaling a strategic move in capital management.

Biotron Limited has completed a $1 million placement to fund the development of its newly acquired Sedarex Limited assets, marking a strategic expansion of its antiviral portfolio.

Ryder Capital Limited has announced an on-market buy-back program targeting up to 7.56 million ordinary shares, signaling a strategic move in capital management starting December 2025.

JPMorgan Asset Management has announced updated cash distribution amounts for December 2025 across four of its Equity Premium Income ETFs, offering investors a clear timetable and participation details for reinvestment.

Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.